ÂÜÀòÂÒÂ×

Kiyoyuki Omoto has a comprehensive work experience spanning various roles and industries. Kiyoyuki is currently a Senior Director at Neomorph, Inc., a position they have held since February 2022. Prior to this, they worked at H3 Biomedicine as an Associate Director from November 2019 to February 2022, and as a Senior Investigator from September 2018 to November 2019. Before joining H3 Biomedicine, they were associated with Pfizer Worldwide Research and Development, where they held the position of Associate Research Fellow from August 2016 to August 2018, and from April 2016 to August 2016. Earlier in their career, they were an Associate Research Fellow at Pfizer Worldwide Research and Development, Neusentis Unit, from June 2011 to April 2016. Kiyoyuki Omoto began their career as a Computational Chemist at Pfizer Global Research and Development in April 2002 and later moved on to become a Principal Scientist from December 2007 to May 2011. Prior to their industry experience, they served as an Assistant Professor at Kyoto University from April 1999 to March 2002.

Kiyoyuki Omoto has a Bachelor's degree in Industrial Chemistry, a Master's degree in Quantum Chemistry, and a PhD in Engineering, specializing in Quantum Chemistry. All of these degrees were obtained from Kyoto University.